Allogeneic Cell Therapy Market Overview The global allogeneic cell therapy market was valued at USD 255.6 million in 2022 and is expected to reach USD 1.72 billion by 2030, growing at a CAGR of 27.4% from 2023 to 2030. This growth is primarily driven by the rising prevalence of chronic conditions such as cancer, cardiovascular diseases, autoimmune disorders, and genetic illnesses, which...